Awl Pharmaceuticals LLP - business services in Farrukhabad, Uttar Pradesh, India. Directors, charges & compliance details.
LLPIN ABZ-9165 Incorporated 23 January 2023 ROC Kanpur HQ Farrukhabad, Uttar Pradesh, India
Active Limited Liability Partnership business services
Data last updated
Contribution obligation
₹20,000
As per LLP agreement
LLP age
3 yrs
Est. 2023
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Kanpur
ROC office
Incorporated
23 Jan 2023
Date of incorporation
Entity type
LLP
As registered with MCA

About Awl Pharmaceuticals LLP

Data last updated:

Awl Pharmaceuticals LLP is a limited liability partnership (LLP) based in Farrukhabad, Uttar Pradesh, India. It operates in the commission-based trading segment of the business services sector. It was incorporated on 23 January 2023.

The LLP is registered with the Registrar of Companies (ROC), Kanpur, under LLPIN ABZ-9165.

The LLP has a total obligation of contribution of β‚Ή20,000. It is led by designated partners Yogesh Kumar and Rajat Singh.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Farrukhabad, Uttar Pradesh.

Company details

LLPIN ABZ-9165
Incorporation Date 23 January 2023
Total Obligation of Contribution β‚Ή20,000
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025

Contact details

Awl Pharmaceuticals LLP's registered office is in Farrukhabad, Uttar Pradesh.

  • Registered Address
    7/212, Jant Singh Ganga Nagar, Farrukhabad, Uttar Pradesh, India – 209625
  • Industry
    Business Services, Commission Trade
Comprehensive company report
Awl Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Awl Pharmaceuticals LLP

FY 2025 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Awl Pharmaceuticals LLP, buy the company report.

Designated partners of Awl Pharmaceuticals LLP

Awl Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Yogesh KumarDesignated Partner23 Jan 20233 Years 9 MonthsCurrent
Rajat SinghDesignated Partner23 Jan 20233 Years 9 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Awl Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Awl Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Awl Pharmaceuticals LLP has 2 designated partner changes on record since 2023: 2 appointments. The latest: Rajat Singh was appointed as Designated Partner on 23 Jan 2023.

AGM
Awl Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Awl Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Rajat Singh was appointed as Designated Partner.
Appointed
Yogesh Kumar was appointed as Designated Partner.
Incorporation
23 Jan 2023
Awl Pharmaceuticals Llp was registered on 23 Jan 2023 with Roc Kanpur & aged 3 years 9 months as per MCA records.

Frequently asked questions

Awl Pharmaceuticals is an active limited liability partnership based in Farrukhabad, Uttar Pradesh, India. The LLP works in commission trade, within the business services industry. It was incorporated on 23 January 2023 (3+ years old) and is registered under LLPIN ABZ-9165.

Awl Pharmaceuticals has 2 current designated partners:

The latest financial statements of Awl Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2023 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Awl Pharmaceuticals is ABZ-9165. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Awl Pharmaceuticals was incorporated on 23 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.

Rajat Singh was appointed as Designated Partner on 23 Jan 2023. Yogesh Kumar was appointed as Designated Partner on 23 Jan 2023.

The registered office of Awl Pharmaceuticals is at 7212, Jant Singh Ganga Nagar, Farrukhabad, Uttar Pradesh, India – 209625.

Awl Pharmaceuticals operates in the business services industry, in the commission trade segment.

Awl Pharmaceuticals can be reached at its registered office: 7212, Jant Singh Ganga Nagar, Farrukhabad, Uttar Pradesh, India – 209625.

Awl Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.